FDA Updates Clozapine Requirements for Neutropenia Risk
Safety Requirements For Clozapine. The U.S. Food and Drug Administration (FDA) is changing certain safety requirements for ‘Clozapine’, a medication used to treat patients with schizophrenia. According to a Drug Safety Communication issued on Sept. 15, the agency is modifying requirements for monitoring, prescribing, … [Read more...] about FDA Updates Clozapine Requirements for Neutropenia Risk
FDA Updates Requirements for Clozapine in Light of Neutropenia Risk
Clozapine May Cause Severe Neutropenia. The U.S. Food and Drug Administration (FDA) is changing certain safety requirements for clozapine, a medication used to treat patients with schizophrenia. According to a Drug Safety Communication issued on Sept. 15, the agency is modifying requirements for monitoring, prescribing, … [Read more...] about FDA Updates Requirements for Clozapine in Light of Neutropenia Risk
